Therefore, between breast tumors, there may be a preference for PD-L1 expression over B7-H4 expression indicated by the immune infiltration or lack thereof, but within tumors or tumor cells, there is no inhibitory effect of the two checkpoint ligands that we observed (i.e., no direct reciprocal regulation). The gene discussed is CD80; the disease is neoplasm.